|
Hypertrophy
Citations 281-290 of 489 total displayed.
|
Past content
(since Jan 1999):
|
- Clinician Update
Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
- Carey D. Kimmelstiel and Barry J. Maron
Circulation 2004;109:452-456, doi:10.1161/01.CIR.0000114144.40315.C0
[Full text]
- Articles
17 -Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor-Cyclic Guanosine Monophosphate-Dependent Protein Kinase Pathway
- Fawzi A. Babiker, Leon J. De Windt, Martin van Eickels, Victor Thijssen, Ronald J.P. Bronsaer, Christian Grohé, Marc van Bilsen, and Pieter A. Doevendans
Circulation published January 12, 2004, doi:10.1161/01.CIR.0000105682.85732.BD
[Abstract]
- Articles
Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes
- Abhinav Diwan, Ziad Dibbs, Shintaro Nemoto, Gilberto DeFreitas, Blase A. Carabello, Natarajan Sivasubramanian, Eric M. Wilson, Francis G. Spinale, and Douglas L. Mann
Circulation published December 29, 2003, doi:10.1161/01.CIR.0000109642.27985.FA
[Abstract]
- Focused Perspectives
Apoptosis Inhibitors for Heart Disease
- Keith A. Webster and Nanette H. Bishopric
Circulation 2003;108:2954-2956, doi:10.1161/01.CIR.0000097188.26010.E8
[Full text]
- Clinical Investigations and Reports
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
- Paul Sorajja, Steve R. Ommen, Rick A. Nishimura, Bernard J. Gersh, Peter B. Berger, and A. Jamil Tajik
Circulation 2003;108:2342-2348; published online before print as doi:10.1161/01.CIR.0000097110.55312.BF
[Abstract]
[Full text]
- Basic Science Reports
Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy
- David B. Averill, Yuichiro Ishiyama, Mark C. Chappell, and Carlos M. Ferrario
Circulation 2003;108:2141-2146; published online before print as doi:10.1161/01.CIR.0000092888.63239.54
[Abstract]
[Full text]
- AHA Scientific Statements
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
- Mark J. Sarnak, Andrew S. Levey, Anton C. Schoolwerth, Josef Coresh, Bruce Culleton, L. Lee Hamm, Peter A. McCullough, Bertram L. Kasiske, Ellie Kelepouris, Michael J. Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J. Spinosa, and Peter W. Wilson
Circulation 2003;108:2154-2169, doi:10.1161/01.CIR.0000095676.90936.80
[Full text]
- Articles
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
- Paul Sorajja, Steve R. Ommen, Rick A. Nishimura, Bernard J. Gersh, Peter B. Berger, and A. Jamil Tajik
Circulation published October 27, 2003, doi:10.1161/01.CIR.0000097110.55312.BF
[Abstract]
- Clinical Investigations and Reports
Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E–Left Ventricular Hypertrophy Study
- Bertram Pitt, Nathaniel Reichek, Roland Willenbrock, Faiez Zannad, Robert A. Phillips, Barbara Roniker, Jay Kleiman, Scott Krause, Daniel Burns, and Gordon H. Williams
Circulation 2003;108:1831-1838; published online before print as doi:10.1161/01.CIR.0000091405.00772.6E
[Abstract]
[Full text]
- Brief Rapid Communications
Angiotensin-(1-7) Formation in the Intact Human Heart: In Vivo Dependence on Angiotensin II as Substrate
- Lawrence S. Zisman, Glenn E. Meixell, Michael R. Bristow, and Charles C. Canver
Circulation 2003;108:1679-1681; published online before print as doi:10.1161/01.CIR.0000094733.61689.D4
[Abstract]
[Full text]
|
|
